Association between NR4A2 genetic variation and schizophrenia: A comprehensive systematic review and meta-analysis.
The homo sapiens nuclear receptor subfamily 4, group A (NR4A2) genetic variation has been implicated as a risk factor for schizophrenia (SZ). Nevertheless, the results are inconclusive. We conducted a comprehensive systematic review and meta-analysis to quantify the impact of NR4A2 variation on the risk of SZ. All eligible case-control studies published up to September 2014 were identified by searching PubMed OVID, EBSCO, PsycINFO and ISI web of knowledge. Pooled odds ratio with 95% confidence interval were used to access the strength of association in fixed- or random-effects model. Seven studies that reported 17 variants with a total of 3027 participants were included. Of these variants, five ones (rs143618355, rs199674295, c.366-369 del TAC, c.-469delG and P4) were present only in cases, and three ones (rs35479735, rs3832066 and rs397706674) were available for meta-analysis. Overall, there was no significant association between the three variants and SZ risk under allele model, dominant model and recessive model. The results failed to reveal significant link between NR4A2 polymorphism and SZ risk. However, large-sized and well-designed studies are warranted to validate our findings.
['Liu|Hongmei|H|', 'Fu|Yingmei|Y|', 'Ren|Juanjuan|J|', 'Yu|Shunying|S|', 'Liu|Hongbo|H|', 'Jiang|Ping|P|', 'Dong|Yi|Y|', 'Li|Huafang|H|']
D016022:Case-Control Studies D056726:Genetic Association Studies D020022:Genetic Predisposition to Disease D006801:Humans D057126:Nuclear Receptor Subfamily 4, Group A, Member 2 D011110:Polymorphism, Genetic D012559:Schizophrenia
NR4A2 Schizophrenia Systematic review Meta-analysis